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During development, major metabolic changes
occur as cells becomemore specialized within a line-
age. In the case of skeletal muscle, differentiation is
accompanied by a switch from a glycolytic prolifera-
tive progenitor state to an oxidative postmitotic
differentiated state. Such changes require extensive
mitochondrial biogenesis leading to increased reac-
tive oxygen species (ROS) production that needs to
be balanced by an antioxidant system. Our analysis
of double conditional Pitx2/3 mouse mutants, both
in vivo during fetal myogenesis and ex vivo in primary
muscle cell cultures, reveals excessive upregulation
of ROS levels leading to DNA damage and apoptosis
of differentiating cells. This is a consequence of
downregulation of Nrf1 and genes for antioxidant
enzymes, direct targets of Pitx2/3, leading to
decreased expression of antioxidant enzymes, as
well as impairment of mitochondrial function. Our
analysis identifies Pitx2 and Pitx3 as key regulators
of the intracellular redox state preventing DNA dam-
age as cells undergo differentiation.
INTRODUCTION
Tissue formation during development depends on tightly regu-
lated steps of progenitor cell self-renewal, transitory amplifica-
tion of tissue-specific precursor cells, and their subsequent
differentiation. The dynamic phenotypic changes that cells un-
dergo during this process include major metabolic adaptation,
as exemplified by skeletal muscle. Myogenic progenitors are
characterized by the expression of Pax3 and Pax7, which are
required both formaintenance of this stem cell population (Relaix
et al., 2005) and for activation of Myf5 and MyoD, which control
entry into the skeletal muscle program (Davis et al., 1987; Wein-
traub et al., 1991). On activation of these myogenic determina-
tion genes, myoblasts proliferate before exiting the cell cycle,
activating the myogenic differentiation gene, Myogenin, and
forming multinucleated differentiated muscle fibers. Gene regu-392 Developmental Cell 29, 392–405, May 27, 2014 ª2014 Elsevier Inlatory networks for both transcription factors and signaling path-
ways involved in myogenesis have been partially identified
(Buckingham and Vincent 2009); however, important aspects
of themyogenic context that affect cell behavior remain obscure.
This is the case for the control of reactive oxygen species (ROS)
that are produced by oxidative phosphorylation when cells
switch from a glycolytic proliferative progenitor state to an oxida-
tive postmitotic differentiated state (Remels et al., 2010; Blan-
chet et al., 2011). The management of these by-products is
critical as they can lead to oxidative stress and cell damage. In
general, the control of ROS levels and of metabolic status is
emerging as an important facet of stem cell biology, as illustrated
by recent results on hematopoietic stem cells (Owusu-Ansah
and Banerjee 2009; Takubo et al., 2010). ROS levels were shown
to increase at the onset of differentiation in immortalized muscle
cell lines (Malinska et al., 2012; Lee et al., 2011), but it is not clear
whether this has functional significance in vivo or how it is regu-
lated. Pitx2 and Pitx3, two genes expressed inmuscle progenitor
cells, have been associated in lens and retina with glaucoma and
cataracts (Amendt et al., 1998; Semina et al., 1996, 1997), two
disorders that involve oxidative stress (Babizhayev, 2012).
During myogenic development, these two genes lie downstream
ofPax3/7 (Lagha et al., 2010; L’honore´ et al., 2010) and upstream
of the myogenic factor genes. While Pitx2 decreases at the
onset of differentiation, Pitx3 is maintained in terminally differen-
tiated cells. In Pitx3mutants, muscle development is not notably
perturbed. Pitx2 transcription, which is normally downregulated,
is maintained in the absence of Pitx3, thus providing compensa-
tion (L’Honore´ et al., 2007).
In this report, we have investigated the roles of Pitx2 and Pitx3 
during fetal myogenesis. Both in vivo by examining the muscle 
phenotypes of conditional Pitx2/Pitx3 double mutants and 
ex vivo in primary myogenic cell cultures, we observed a deficit 
in skeletal muscle due to cell death of myogenic cells at the onset 
of differentiation. We found an essential role for Pitx2 and Pitx3 in 
the management of ROS during the transition from proliferation 
to differentiation. In the absence of both Pitx factors, differenti-
ating myoblasts accumulate abnormally high levels of ROS, 
leading to irreversible DNA damage and apoptosis. We demon-
strate that this excessive level is largely due to deficient expres-
sion of the transcription factor nuclear respiratory factor 1 (Nrf1) 
and of its target genes implicated in mitochondrial respiration and in 




Redox Regulation by Pitx2/3 during Myogenesiswe show that Pitx2 and Pitx3 are direct regulators of both Nrf1
and its antioxidant targets, demonstrating two levels of ROS
regulation by these transcription factors.
RESULTS
Absence of Pitx2/3 Impairs Skeletal Muscle
Development
In view of the apparent compensation of Pitx3 deficiency by
Pitx2, we evaluated the involvement of both factors in fetal myo-
genesis usingPitx2:Pitx3 double conditional mutants. In contrast
to embryonic myogenesis when only Pitx2 is expressed in Pax3-
positive progenitors (L’Honore´ et al., 2007), during fetal myogen-
esis, both Pitx2 and Pitx3 are present in progenitors labeled by
Pax7 (Figures S1A–S1F and S1M available online), and early
differentiating cells marked by Myogenin (Figures S1G–S1L),
before subsequent downregulation of Pitx2 in differentiated cells
(L’Honore´ et al., 2007). In order to delete conditional alleles of
these genes prior to the onset of myogenesis, we used the trans-
genic MSD-cre line, in which Cre recombinase is expressed
throughout the paraxial mesoderm (Beckers et al., 2000), or for
differentiated muscle, an HSA-cre line where the human skeletal
actin (HSA) promoter directsCre expression (Miniou et al., 1999).
Using the conditional reporter alleles R26RmTomato-STOP-mGFP
and R26RnLacZ, we confirmed the robust expression of the re-
porter gene in the myogenic lineage of the trunk and limbs in
these Cre lines (Figures S1N and S1O) and the effective loss of
Pitx2/3 expression (Figure S1P). Pitx2flox/flox:Pitx3/flox:MSD-cre
mutants die at birth and can be easily distinguished from their
littermates. They are smaller, display a bent posture, and have
an enlarged abdomen compared to controls. This phenotype is
already observed at embryonic day (E)15.5 (Figures S1Q and
S1R) and is suggestive of inadequate development of the
musculature, especially in the trunk (Grifone et al., 2005). To
analyze the consequences of deletion of Pitx2/3 genes, we first
examined the development of trunk and limb skeletal muscles
at E13.5 in the presence of the MSD-cre transgene. Whole-
mount in situ hybridization with a Myogenin probe showed a
striking reduction in skeletal muscle in the body (Figures 1A
and 1B). As this reduction was not equal in all muscles, and to
check the activity of the MSD-cre transgene, we performed the
Pitx2 and Pitx3 deletion using the Pax3cre/+ line. Myogenin
expression of Pitx2flox/flox:Pitx3/flox:Pax3cre/+ embryos at E13.5
(Figures S1S and S1T) displayed a pattern similar to that of
Pitx2flox/flox:Pitx3/flox:MSD-cre mutants, demonstrating variable
sensitivity of different muscles to the absence of Pitx2/3. In view
of the coexpression of the two Pitx2/3 genes in progenitor cells
and early differentiating cells, we then examined potential de-
fects at both stages that might lead to the impairment in mutant
muscle differentiation. Using TUNEL immunofluorescence stain-
ing, we observed a major increase in apoptosis in developing
skeletal muscle in E12.5 mutant embryos crossed with the
MSD-cre line (Figures 1F–1H, 1L, and 1M), compared to control
embryos (Figures 1C–1E and 1M). Such cell death is first de-
tected at E11.5 (data not shown) and still observed in mutant
embryos later during development at E16.5 (Figures 1N and
1O). We did not find any significant difference in the number of
Pax7-positive progenitor cells in mutant versus control embryos
at E13.5 (Figure S1U) and at E16.5 (data not shown), suggestingDevethat the absence of Pitx2 and Pitx3 does not affect the prolifera-
tion or survival of Pax7-positive myogenic progenitors. Consis-
tent with this, we did not detect an increased number of Pax7/
TUNEL double-positive cells in mutant embryos compared to
controls (Figures 1C, 1F, and 1L). However, we observed that
a large proportion of cells that were undergoing apoptosis
were also marked by Myogenin (61%) and MF20 (42%)
expression (Figures 1G, 1H, and 1L). We then examined the
consequences of impaired expression of Pitx2 and Pitx3 in
differentiated cells and did not detect any significant apoptosis
in muscle masses of Pitx2flox/flox:Pitx3/flox:HSA-Cre mutants
either at E12.5 (Figures 1I–1K and 1M) or E16.5 (Figure 1P). Alto-
gether, these data demonstrate that loss of Pitx2/3 gene expres-
sion in the myogenic lineage leads to impaired myogenesis due
to apoptosis of cells at the onset of differentiation.
Ex Vivo Deletion of Pitx2 and Pitx3 in Fetal Muscle
Progenitors Results in Apoptosis of Differentiating
Myoblasts, Leading to Defective Myogenesis
To explore the mechanism by which the absence of Pitx2/3
affects muscle cell survival, we next carried out conditional abla-
tion of both genes in primary cultures of myogenic progenitors
isolated from fetal muscle. We generated Pitx2flox/flox:Pitx3/flox:
R26Rcre-ERT2/+:Pax3GFP/+ embryos, which facilitated the direct
isolation of Pax3(GFP)-positive muscle progenitor cells by flow
cytometry (Montarras et al., 2005; Figure S2A). We first validated
the myogenic identity of green fluorescent protein (GFP)-sorted
cells isolated from Pax3GFP/+ embryos and confirmed that
more than 98%of the cells expressedMyoD after 48 hr in culture
(Figure S2B). Using immunocytochemistry with an antibody that
recognizes both Pitx2 and Pitx3, and antibodies to MyoD,
Myogenin, P21, and Troponin T, we showed that the pattern of
expression of Pitx2/3 ex vivo in control Pax3GFP/+ cells (Figures
S2C and S2D) is similar to what we had previously observed
in vivo (Figures S1A–S1L). After addition of 4-hydroxytamoxifen
(4-OHT) to the culture medium (Figure S2E), recombination of
both Pitx2 and Pitx3 alleles was complete after 36 hr of culture
(Figure S2F), leading to the complete absence of Pitx2/3 staining
by immunocytochemistry at 48 hr (Figure S2G). We then investi-
gated the consequences of Pitx2/3 deletion on ex vivo myogen-
esis. Deletion of Pitx2 and Pitx3 genes affects expansion of the
population (see DAPI in Figure 2A) and leads to defective differ-
entiation marked morphologically by the absence of multinucle-
atedmyotubes after 120 hr of culture (Figure 2A, phase contrast),
while 4-OHT treatment of control cells has no effect (Figure S2H).
This phenotype is illustrated by the large reduction in Troponin T
expression at 120 hr (Figures 2A and 2C). We then followed
sequential expression of progenitor and differentiating cell
markers. We did not detect any differences in the number of pro-
genitors marked by expression of Pax7 (Figures S2I and S2K).
Unlike the situation during embryonic myogenesis in the limb
(L’honore´ et al., 2010), MyoD is normally expressed in activated
cells in the absence of Pitx2/3 (Figures S2I and S2K). The onset
of differentiation occurs similarly in control and mutant cells, as
shown by Myogenin expression at 72 hr (Figures 2B and 2C).
However, by 96 hr, we observed a striking decrease (50%) in
the mutant population compared to controls (Figures 2B and
2C). This decrease is essentially due to a reduction in the number








Figure 1. Inactivation of Pitx2/3 Leads to Defective Differentiation
during Fetal Myogenesis
(A and B) Whole-mount in situ hybridization with a probe forMyogenin RNA on
(A) controlPitx2flox/flox:Pitx3/flox:wt and (B)mutantPitx2flox/flox:Pitx3/flox:MSD-
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leads to an increased proportion of the Pax7-expressing cells
in the population, as shown by reverse transcription followed
by quantitative real-time PCR (qPCR) analysis of transcripts
(Figure 2D).
We observed a severe increase in apoptosis in mutant cells
compared to controls (Figures 2E and 2F), in agreement with
in vivo results obtained with Pitx2flox/flox:Pitx3/flox:MSD-cre mu-
tants (Figures 1F–1H, 1L, and 1M). This apoptosis, marked by an
increase of p53 and Noxa expression (Figure 2G), is first de-
tected at the onset of differentiation, at 72 hr, and is high after
96 hr of culture (Figure 2F). In keeping with what we observed
in Pitx2flox/flox:Pitx3/flox:HSA-cre mutants (Figures 1I–1K and
1M), deletion of Pitx2/3 by the addition of 4-OHT at 72 hr did
not affect the survival of differentiated cells (Figures 2E and
2F), with the same number of cellsmarked by Troponin T (Figures
S2J and S2K).
Defects in cell cycle arrest at the onset of differentiation can
lead to endoreplication of myotube nuclei and to their apoptosis
(Zacksenhaus et al., 1996; Jiang et al., 2000). As Pitx genes have
been implicated in upregulation of p21 (Wei and Adelstein 2002;
Cao et al., 2010), we investigated whether Pitx2/3 mutant cells
exit the cell cycle normally. At 72 hr, all Myogenin-positive cells
were also marked by p21 expression in the presence or absence
of Pitx2/3 (Figures S3A and S3B). Furthermore, mutant cells
marked byMyogenin expression did not show increased 5-ethy-
nyl 20 deoxyuridine (EdU) incorporation compared to controls
(Figures S3C and S3D), demonstrating that, in the absence of
Pitx2 and Pitx3, cells cease DNA synthesis and exit the cell cycle
normally at the onset of differentiation.
Pitx2/3Mutant Cells Exhibit Abnormal ROS Levels, with
Accumulation of DNA Damage during Differentiation,
and Are Rescued by Antioxidants
Ex vivo deletion of Pitx2/3 reproduced our in vivo results showing
apoptosis of myogenic cells at the onset of differentiation.cre embryos at E13.5 shown in lateral views. Black arrowheads point to dif-
ferences in expression. The experiments were performed with at least three
embryos, and a representative picture of each genotype is shown.
(C–K) Coimmunohistochemistry on transverse sections of thoracic somites
from (C–E) control Pitx2flox/flox:Pitx3/flox:wt, (F–H) mutant Pitx2flox/flox:
Pitx3/flox:MSD-cre, and (I–K) mutant Pitx2flox/flox:Pitx3/flox:HSA-cre embryos
at E12.5 costained with the TUNEL reaction (red) and Pax7 (in C, F, and I);
myogenin (Myog in D, G, and J), or muscle myosin heavy chain (MF20 in E, H,
and K) antibodies. Scale bars, 20 mM.
(L) Quantification of the number of TUNEL-positive nuclei that express Pax7,
Myogenin (Myog), or muscle Myosin Heavy Chain (MF20), shown as a per-
centage of the total TUNEL-positive population for mutant Pitx2flox/flox:
Pitx3/flox:MSD-cre embryos at E12.5 (n = 3 embryos, mean ± SD, *p < 0.05).
Pax7/TUNEL-, Myogenin/TUNEL-, and MF20/TUNEL-positive nuclei were
counted and expressed as a percentage of the total TUNEL-positive
population.
(M) Quantification of the percentage of nuclei that are TUNEL positive for
control Pitx2flox/flox:Pitx3/flox:wt (:wt), mutant Pitx2flox/flox:Pitx3/flox:MSD-cre
(:MSD) and mutant Pitx2flox/floc:Pitx3/flox:HSA-cre (:HSA) embryos at E12.5
(n = 3 embryos for each genotype; mean ± SD, *p < 0.05).
(N–P) Sagittal sections at shoulder level of E16.5 (N) control Pitx2flox/flox:
Pitx3/flox:wt, (O) mutant Pitx2flox/flox:Pitx3/flox:MSD-cre, and (P) mutant
Pitx2flox/flox:Pitx3/flox:HSA-cre embryos stained for TUNEL activity. Open





Figure 2. Ex Vivo Inactivation of Pitx2/3 Leads to Defective Differentiation due to Apoptosis of Differentiating Myoblasts
(A–C) GFP-positive cells, isolated from inducible mutant Pitx2flox/flox:Pitx3/flox:Pax3GFP/+:R26RCre-ERT2/+ embryos at E13.5 were cultured (A) for 120 hr and (B) for
72 hr and 96 hr and in the presence or absence (Ctrl) of 0.5 mM4-OHT. Cells were stained with DAPI and by immunocytochemistry withMyogenin (green) antibody
at 72 hr and 96 hr in (B) and with Troponin T (TnT, red) antibody at 120 hr, with phase contrast images on the left in (A). Scale bars, 20 mM. (C) Results were
quantified by counting positive and negative nuclei for each marker. Data represent the mean number of nuclei counted in more than 10 areas per plate for
cultures from three embryos under each condition. t, time.
(D) GFP-positive cells, isolated as described in (A) through (C), were cultured in the presence or absence (Ctrl) of 0.5 mM4-OHT. After 96 hr of culture, transcripts,
as indicated, were analyzed by qPCR, shown relative to Gapdh transcripts, and standardized to the control as one. nd, not detectable.
(E–G) GFP-positive cells, isolated as for (A), were cultured in the presence or absence (Ctrl) of 0.5 mM 4-OHT added at the beginning of the culture (for 4-OHT) or
after 72 hr (4-OHT72) and processed for TUNEL staining at the times indicated. (E) TUNEL staining (green) of DAPI-treated cells after 96 hr of culture. White
arrowheads point to TUNEL-positive cells. Scale bars, 20 mM. (F) Quantification of the percentage of TUNEL-positive cells at each time point. (G) After 96 hr of
culture, qPCR of p53 and Noxa transcripts.
In (C), (D), (F), and (G), n = 3 embryos; mean ± SD, *p < 0.05.
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appeared even more pronounced than in vivo, with the nearly
complete absence of differentiated cells after 120 hr of culture.
These differences suggested that culture conditions exacer-
bated the mutant phenotype. Since our standard primary culture
conditions are under atmospheric (20%) oxygen, we postulated
that oxidative stress might be implicated in cell survival failure ofDevePitx2/3 mutant cells (Abbas et al., 2010). We thus investigated
whether mutant cells exhibited higher levels of intracellular
ROS than their controls at the onset of differentiation. To purify
progenitor and differentiating muscle cells from embryos, we
took advantage of the relative stability of the GFP reporter that
continues to be detectable at a lower level in Pax3GFP/+ differen-




Figure 3. Pitx2/3 Mutant Cells Accumulate Abnormal Levels of ROS, Leading to Apoptosis and Impaired Terminal Differentiation
(A) Mutant Pitx2flox/flox:Pitx3/flox:Pax3GFP/+:R26RCre-ERT2/+, and control Pitx2flox/+:Pitx3/+:Pax3GFP/+:R26RCre-ERT2/+ embryos at E13.5 were obtained by 4-OHT
intraperitoneal injection of pregnant mothers at E8.5 and used for isolation by flow cytometry of two populations, Pax3GFP-High and Pax3GFP-Low, based on their
level of expression of GFP. Immediately after purification, cells were incubated with Cell Rox and analyzed by flow cytometry to measure GFP and Cell Rox
fluorescence intensity.
(B) The whole GFP-positive cell population (High and Low), isolated from inducible mutant Pitx2flox/flox:Pitx3/flox:Pax3GFP/+:R26RCre-ERT2/+ embryos at E13.5, was
cultured for 72 hr in the presence of 0.5 mM4-OHT, incubated with Cell Rox, trypsinized, and analyzed by flow cytometry to measure fluorescence intensity. As a
control, Pitx2/3 mutant cells (+4-OHT) were treated with the antioxidant NAC (10 mM) for 3 hr before Cell Rox incubation.
(C) GFP-positive cells, isolated from control Pitx2flox/flox:Pitx3/flox:Pax3GFP/+:R26R+/+ and inducible mutant Pitx2flox/flox:Pitx3/flox:Pax3GFP/+:R26RCre-ERT2/+
embryos at E13.5, were cultured for 72 hr in the presence of 0.5 mM4-OHT, incubated with Cell Rox, and analyzed by fluorescencemicroscopy. Scale bars, 5 mM.
(D–F) In (D), GFP-positive cells, isolated as in (B), were cultured in the presence or absence (Ctrl) of 0.5 mM 4-OHT. After 48 hr and 72 hr of culture, cells were
stained with DAPI and analyzed by immunocytochemistry using Myogenin and gH2AX antibodies. Scale bars in (D) represent 20 mM.
(E) gH2AX-positive cells were counted at 48 hr and 72 hr in control and mutant cultures, represented as the percentage of total cells.
(F) Myogenin-positive cells were counted and quantified as the percentage of total gH2AX-positive cells in the mutant (4-OHT) population at 72 hr (n = 3 embryos;
mean ± SD, *p < 0.05).
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embryos were separated by flow cytometry into Pax3GFP-High
(Figure 3A, blue) and Pax3GFP-Low (Figure 3A, red) fractions and
immediately processed for western blot analysis using Troponin
T and phospho-histone-H3 antibodies (Figure S3E) or for ROS
detection. Pax3GFP-High and Pax3GFP-Low populations of control
and mutant cells were incubated with Cell Rox reagent, and
the fluorescent signal was measured by flow cytometry (Fig-
ure 3A). First, using control cells, we noted a significant increase396 Developmental Cell 29, 392–405, May 27, 2014 ª2014 Elsevier Inof ROS in Pax3GFP-Low differentiating cells, compared to
Pax3GFP-High progenitor cells (Figure 3A). In mutant cells, this in-
crease in Pax3GFP-Low cells was greatly enhanced, while, in
contrast, progenitor cells (Pax3GFP-High) had a similar level of
ROS compared to controls. This abnormally high level of ROS
in mutant differentiating cells was confirmed ex vivo by flow
cytometry (Figure 3B) and by microscopy (Figure 3C) in control
and mutant cells after 72 hr of culture. As expected, treatment
of cells with N-acetyl-cysteine (NAC), a strong antioxidant thatc.
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reversed this upregulation (Figure 3B), demonstrating that dele-
tion of Pitx2/3 genes leads to an increase of oxidative stress in
differentiating cells. Excessive ROS levels can lead to DNA dam-
age (Karanjawala et al., 2002), whichmay trigger apoptosis if this
reaches a critical threshold that compromises genomic stability
(Shiloh, 2003). In Pitx2/3 mutant cells, we found a significant in-
crease of cells with gH2AX foci (Figures 3D and 3E), markers of
DNA damage signaling (Bonner et al., 2008), compared to the
control. It is important to note that this increase occurs at the
onset of differentiation (t = 72 hr), in Myogenin-positive cells (Fig-
ures 3D and 3F) and correlates with the high level of intracellular
ROS (Figures 3B and 3C). Overall, these results suggest that the
excessive level of ROS observed in myogenic cells depleted of
Pitx2/3 is responsible for the accumulation of irreversible DNA
damage, leading to subsequent cell apoptosis.
To reduce the oxidative stress, we first performed cultures
under 3% O2. We observed a moderate reduction of apoptosis
correlated with a small increase in differentiation in the absence
of Pitx2/3 (Figures 4A and 4B); indeed, the low oxygen conditions
had aminor effect on the level of intracellular ROS (Figure 4C). To
efficiently decrease this level, we supplemented the culture
mediumwith the antioxidant NAC at day 0 of culture and then fol-
lowed the survival and differentiation of control and mutant cells
after culture under 20% (Figures 4D–4H) and 3%O2 (Figures 4F–
4H). NAC treatment performed either under 20% or 3% O2 cul-
ture conditions efficiently reduced the number of gH2AX-positive
cells in Pitx2/3mutant cultures (Figure 4G), resulting inmuch less
apoptosis of mutant cells (Figure 4H) and rescued differentiation
(Figures 4B and 4C). Similar results were obtained using two
different antioxidants, Trolox and Resveratrol (Figures S4A and
S4B), thus demonstrating that the abnormal increase of ROS
levels observed in cells depleted for Pitx2/3 is directly respon-
sible for their altered terminal differentiation.
Pitx2/3 Fine-Tune the Expression of the Antioxidant
System through Regulation of Nrf1 and Antioxidant
Enzymes during Differentiation
ROS are formed as by-products of aerobic respiration and are
mainly generated by the mitochondrial respiratory chain.
Myogenic differentiation is accompanied by major metabolic
changes, when cells switch from a glycolytic proliferative pro-
genitor state to an oxidative postmitotic differentiated state
(Remels et al., 2010; Blanchet et al., 2011). Such changes require
extensive mitochondrial biogenesis that takes place at the onset
of differentiation and leads to increased ROS production (Fig-
ure 3A; Malinska et al., 2012). To protect cells from oxidative
damage, this intracellular oxidant activity needs to be balanced
by an antioxidant system composed of scavenging and detoxi-
fying enzymes (Sena and Chandel, 2012). It is interesting that
Aldh1a1, encoding Aldehyde dehydrogenase 1a1, an enzyme
that detoxifies oxidized aldehydic products (Vasiliou et al.,
2004; Jean et al., 2011), had been identified previously as a
direct target of Pitx3 in midbrain dopaminergic neurons (Jacobs
et al., 2007). We therefore investigated whether Pitx2/3 may
regulate part of the antioxidant system in muscle cells leading
to increased ROS levels in their absence. We first assessed
in vivo expression of the antioxidant system. Pax3GFP-High
and Pax3GFP-Low fractions were isolated from control E13.5DevePax3GFP/+ embryos and processed for mRNA extraction. Tran-
script levels for markers of mitochondrial function (Cox5a,
NdUfv1; Bourens et al., 2013) and oxidative metabolism
(PGC1a, Eno3; Patti et al., 2003) demonstrated the metabolic
shift occurring at the onset of differentiation in Pax3GFP-Low cells
(Figures 5A and S5A). We found significant upregulation of
antioxidant genes in these cells compared to Pax3GFP-High pro-
genitor cells (Figures 5A and S5A), thus establishing a direct
correlation between the metabolic shift occurring at the onset
of differentiation and the activation of the antioxidant system.
We then examined the kinetics of this coregulation ex vivo.
Consistent with the in vivo results, most of the antioxidant genes
were found to be upregulated at 72 hr of culture, when the major
onset of differentiation occurs and the expression of both Pitx2/3
genes increases (Figure S5B). We next investigated whether this
activation occurs normally during differentiation of Pitx2/3
mutant cells. Quantification of mRNA levels after 72 hr of culture
revealed an upregulation of transcripts for Gpx3 and PGC1a in
mutant cells (Figure 5B), an expected response to the abnormal
increase of ROS (Ufer and Wang, 2011). We also observed a
concomitant and consistent decreased expression of Aldh1a1,
Mt1, Gsta1, Nrf1, and SOD1 in mutant cells compared to con-
trols both at mRNA (Figure 5B) and at protein levels (Figure 5D).
This decreasewas confirmed in vivo in Pax3GFP-Low cells isolated
from control and mutant embryos (Figure 5C) and, as expected,
leads to a significant reduction of the total antioxidant capacity
(TAC) of differentiating Pitx2/3 mutant cells both in vivo and
ex vivo (Figures 5E and S5C).
We next investigated the molecular mechanism underlying the 
decreased expression of this antioxidant system in Pitx2/3-
depleted cells. In silico analysis shows that the promoters of 
antioxidant genes such as SOD1, Mt1, Gsta1, and Aldha1a also have 
binding sites for the nuclear respiratory factor 1 (Nrf1) (Satoh et al., 
2013), now commonly abbreviated as NRF1 but referred to here as 
Nrf1. In view of the downregulation of Nrf1 in Pitx2/3 mutant cells 
(Figure 5B), we postulated that Pitx2/3 might regulate 
antioxidant genes through the direct activation of Nrf1. Using 
ChIP on E13.5 embryos, we first showed a strong recruitment of 
Pitx2/3 on Pitx response elements (PitxRE) local-ized in 
regulatory regions of Nrf1 (Figure 5F). Pitx2 and Pitx3 can 
transactivate these regions in a heterologous cell system, and 
mutations of both PitxRE completely abolish this activation 
(Figure 5G). We found a similar activation of the Aldh1a1 pro-
moter by Pitx2 and Pitx3, consistent with strong recruitment of 
both Pitx2/3 on these sequences in vivo (Figure 5H). We also 
observed direct binding of Nrf1 to Mt1, SOD1, and Gsta1 regula-
tory regions in vivo (Figure 5H). Analysis of the Aldh1a1 promoter 
revealed the presence of a nuclear respiratory factor binding site, 
and efficient binding of Nrf1 to this sequence was confirmed 
(Figure 5H), suggesting a possible coregulation of antioxidant 
genes by both Pitx2/3 and Nrf1. To investigate this hypothesis, 
we searched in silico for PitxRE near nuclear respiratory factor 
binding sites and identified the presence of both sites in the 
regulatory environment of Mt1, SOD1, and Gsta1 genes, in 
agreement with our ChIP identification of Pitx2/3 on these reg-
ulatory regions (Figure 5H). Taken together with our analysis of 
ROS levels in control and mutant cells (Figures 3A–3C), these 
results thus support a two-level regulation of the antioxidant 
pathway by Pitx2/3 (Figure 5I), occurring at the onset of 
differentiation when high metabolic needs require extensive





Figure 4. Rescue of the Differentiation Defect of Pitx2/3 Mutant Cells by Use of Antioxidants
(A–C) GFP-positive cells, isolated from induciblemutant Pitx2flox/flox:Pitx3/flox:Pax3GFP/+:R26RCre-ERT2/+ embryos at E13.5, were cultured in the presence (4-OHT)
or absence (Ctrl) of 0.5 mM 4-OHT. Cells were either cultured under 20%O2 (Ctrl and 4-OHT) or 3%O2 (4-OHT 3%O2) for 96 hr and 120 hr and processed for (A)
TUNEL staining and (B) Troponin T (TnT) staining or (C) incubated with Cell Rox, trypsinized, and analyzed by flow cytometry to measure fluorescence intensity.
(A) TUNEL-positive cells or (B) Troponin T-positive cells were counted and quantified as the percentage of total cells. ROS levels are expressed as absolute units
(A.U.) (n = 3 embryos; mean ± SD, *p < 0.05).
(D–H) GFP-positive cells, isolated from inducible mutant Pitx2flox/flox:Pitx3/flox:Pax3GFP/+:R26RCre-ERT2/+ embryos at E13.5, were cultured in the presence of
0.5 mM4-OHTwith or without 5mMNAC (added at t0). Cells were cultured either under 20%O2 (Ctrl and 4-OHT) or 3%O2 (4-OHT, 3%O2; 4-OHT +NAC, 3%O2).
Cells were visualized under phase contrast after 120 hr of culture, as shown in (D), or analyzed by immunocytochemistry with Myogenin, Troponin T, and gH2AX
antibodies and by the TUNEL reaction after 72 hr or 96 hr of culture, as shown in (E) through (H). In (E), immunofluorescence onDAPI-stained cells with aMyogenin
antibody after 96 hr of culture is shown. In (F) through (H), Myogenin-, Troponin T-, gH2AX-, and TUNEL-positive cells were counted and quantified as the
percentage of total cells (n = 4 embryos; mean ± SD, *p < 0.05). Scale bars, 20 mM.
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Redox Regulation by Pitx2/3 during Myogenesismitochondrial biogenesis. To investigate whether such regula-
tion can also occur in the absence of metabolic demand, control
and mutant cells were treated when still proliferating, after 36 hr
of culture, with buthionine sulfoximine (BSO), an inhibitor of398 Developmental Cell 29, 392–405, May 27, 2014 ª2014 Elsevier Ing-glutamylcysteine synthetase (Griffith 1982) to deplete gluta-
thione (GSH). In contrast to control cells in which such depletion
(Figure S5E) leads to significant induction of the antioxidant
pathway (Figure S5F), and thus moderate increase of ROS levelsc.
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cells revealed a defective activation of this pathway leading to a
large increase of ROS levels and cell death after 18 hr of
treatment (Figures S5G and S5H). These results demonstrate
the essential role of Pitx2 and Pitx3 in the activation of antioxi-
dant genes in response to high levels of ROS induced either by
increase of metabolic activity during differentiation or acute
induced oxidative stress.
Pitx2/3 Mutant Cells Exhibit Defective Mitochondrial
Function, Leading to Overproduction of ROS during
Differentiation
To investigate whether the defective activation of the antioxi-
dant pathway is sufficient to induce the abnormally high levels
of intracellular ROS observed in Pitx2/3 mutant cells, wild-
type fetal cells isolated from Pax3GFP/+ embryos were trans-
fected with siRNA directed against SOD1, Mt1, and Gsta1 tran-
scripts (Figure 6A). Efficient inhibition of the expression of these
three genes (Figure S6A) leads to severe apoptosis of cells after
96 hr of culture (Figure 6C), as a consequence of an increase of
ROS levels (Figure 6B); however, while significant, this increase
does not reach that of Pitx2/3 mutant cells. This result sug-
gested that the defective expression of scavenging enzymes
was not sufficient to induce the high ROS levels of Pitx2/3-defi-
cient cells. In addition to its regulation of antioxidant genes, Nrf1
also plays a key role in integrating the transcription of nuclear-
and mitochondrial-encoded genes. Nrf1 target genes include
subunits of the mitochondrial respiratory complexes such as
cytochrome C, and the transcription factor A Tfam, which tran-
scribes the mitochondrial genome (Kelly and Scarpulla, 2004).
As alteration in expression of these genes can lead to mito-
chondrial dysfunction, a major cause of ROS overproduction,
we investigated their expression in Pitx2/3 mutant cells. Quan-
tification of their transcripts both in vivo in Pax3GFP-Low cells iso-
lated from control and mutant embryos (Figure 6D) and ex vivo
after 72 hr of culture (Figure S6B) revealed a consistent
decrease of their expression as well as that of two Tfam target
genes Ndufv1 and Ndufb6. We then investigated markers of
mitochondrial function in mutant cells compared to controls
and observed an alteration of the cellular bioenergetic state as
evidenced by the decrease in the NAD+/NADH ratio (Figures
6E and S6C), together with a reduction in the intracellular ATP
content (Figure 6F). Quantification of mitochondrial ROS by incu-
bation of cells withMitosox after 72 hr of culture revealed a higher
rate of ROSproduction inmutant cells compared to controls (Fig-
ure 6G). Overall, these results suggest that, in Pitx2/3 mutant
cells, the altered expression of Nrf1 and of its target genes is
responsible for both mitochondrial dysfunction, leading to ROS
overgeneration, and concomitant defective expression of the
antioxidant system, leading to decreased ROS scavenging. As
these two events occur at the onset of differentiation, when
high metabolic needs require increased oxidative phosphoryla-
tion, we investigated whether inhibition of mitochondrial biogen-
esis, and thus of oxidative phosphorylation, by depletion of Tfam
(Lee et al., 2011) might prevent mutant cell differentiation and
their apoptosis.Pitx2/3mutant cells were transfectedwith siRNA
directed against Tfam (Figure 6H). As expected, the inhibition of
Tfam expression (Figure S6D) prevented mutant cell differentia-
tion (Figure 6I), leading to an increase in cell number by mainte-Devenance of proliferation and to a significant rescue of apoptosis
(Figure 6J).
To confirm the direct correlation between Nrf1 downregulation
and the phenotype of Pitx2/3-deficient cells, we restored
Nrf1 expression in mutant cells through lentiviral infection. As
expected, Nrf1 overexpression (Figure S7A) prevented the
abnormal increase of ROS (Figure 7C) both by activating the
expression of the antioxidant system and by preventing mito-
chondrial dysfunction through rescued expression of Tfam
(Figure S7B). This resulted in a significant rescue of the differen-
tiation of mutant cells, as evidenced by Troponin T expression
(Figures 7A and 7B) and the level of Myogenin transcripts (Fig-
ure S7A). We therefore conclude that Pitx2/3, through their con-
trol of the Nrf1 gene, are critical regulators of the redox state of
myogenic cells and that this is necessary for their survival and
their differentiation.
DISCUSSION
Our analysis of the role of Pitx2 and Pitx3 during fetal myogene-
sis reveals an essential role in regulation of intracellular redox
levels during differentiation (Figure 7D). In their absence, ROS
accumulate to pathological levels at the onset of differentiation,
leading to DNA damage and consequent death of differentiating
cells (Figure 7E).
Major metabolic changes occur as cells become more 
specialized within a differentiated lineage. In the case of 
myogenic cells, these changes are of particular interest, specif-
ically as cells switch from a glycolytic proliferative progenitor 
state to an oxidative postmitotic differentiated state. Previous 
studies have correlated this metabolic shift with an increase of 
intracellular ROS levels in immortalized adult cell lines (Malinska 
et al., 2012; Lee et al., 2011). However, very little is known about 
redox levels of myogenic cells in vivo during development or 
about the regulation of genes involved in ROS control (Sena 
and Chandel, 2012). We have found an increase of ROS levels 
occurring in vivo at the onset of differentiation and have identified 
the Pitx2/3 transcription factors as essential regulators of this 
process. In Pitx2/3 mutant muscle cells, ROS increase is deregu-
lated, leading to excessive accumulation of ROS and further cell 
death. We have shown that this is due to downregulation of the 
nuclear respiratory factor 1 (Nrf1), a transcription factor that is 
essential for the coordination of mitochondrial function (Kelly 
and Scarpulla, 2004) and that we identified as critical for the fine-
tuning of the level of antioxidant enzymes. The decreased 
expression of Nrf1 and a subset of its targets are responsible for 
both impaired mitochondrial activity leading to ROS 
overgeneration and deficient activation of the antioxidant 
pathway (Figures 7C and 7D). Furthermore, using ChIP, transac-
tivation assays, and lentiviral rescue, we show direct regulation 
of Nrf1 by Pitx2/3 with joint binding of Nrf1 and Pitx2/3 on down-
stream antioxidant target genes. These results place Pitx2/3 as 
core regulators of redox control during myogenic differentiation.
It is interesting that expression of the detoxifying enzyme, 
Aldh1a1, is downregulated in Pitx2/3 mutant muscle and that 
direct regulation by Pitx3 was also shown in midbrain dopami-
nergic neurons (Jacobs et al., 2007). In these neurons, Pitx3 
has a survival function (van den Munckhof et al., 2003), and 
Parkinson’s disease, in which Pitx3-positive dopaminergic neu-
rons are specifically affected, has been linked to oxidative stress






Figure 5. Pitx2/3 Directly Regulate Transcription Factors and Enzymes that Protect against Oxidative Damage
(A) Two populations, Pax3GFP-High and Pax3GFP-Low, were isolated by flow cytometry from Pax3GFP/+ embryos at E13.5 based on their level of expression of GFP.
RNA samples were analyzed by qPCR for transcripts of proliferation markers, myogenic transcription factors, antioxidant enzymes and transcription factors, and
mitochondrial and metabolic genes, relative to the level of Gapdh transcripts. The data are represented as a heat map.
(legend continued on next page)
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Redox Regulation by Pitx2/3 during Myogenesis(Varc¸in et al., 2011). Similarly in the eye, in both the retina where
Pitx2 is expressed and in the Pitx3-positive lens, mutations in
mice and humans have been associated with downregulation
of Aldh1a1 (Paylakhi et al., 2011) and with glaucoma and cata-
racts (Amendt et al., 1998; Semina et al., 1996, 1997), two
disorders in which oxidative stress has also been implicated
(Babizhayev, 2012). We therefore speculate that the regulation
of the redox state that we have identified during fetal myogenesis
is a common property of Pitx transcription factors at their
different sites of expression.
In vivo, the cell death that we observed in developing fetal
muscle masses in the absence of Pitx2/3 leads to a striking
deficit in skeletal muscle. This is observed when the conditional
Pitx2/3 alleles are mutated early in paraxial mesoderm, using the
MSD-Cre line, but not when the deletion occurs in differentiated
muscle fibers, using the HSA-Cre line. This is consistent with a
role of Pitx2/3 in activation of the antioxidant pathways through
Nrf1 and its target genes and with their role at the onset of differ-
entiation. Embryonic and fetal myoblasts have characteristic
properties (Biressi et al., 2007), and distinct transcriptional regu-
lators of embryonic and fetal muscle differentiation have begun
to be identified (Hutcheson et al., 2009; Messina et al., 2010).
Expression of the myogenic determination gene MyoD is not
compromised in the Pitx2/3 mutant at fetal stages, a phenotype
that differs from that in embryonic muscle, where Pitx2, acting
downstream of Pax3, is required for MyoD expression through
direct activation of the MyoD embryonic enhancer (L’honore´
et al., 2010). These different functional requirements for Pitx fac-
tors underline the differences between embryonic and fetal myo-
genesis. In the context of oxidative stress, with the introduction
of the chorio-allantoic circulation, the fetus is exposed to higher
oxygen levels (Ufer and Wang, 2011), making it more vulnerable
to the increase of ROS observed in the absence of Pitx2/3 than
during embryonic myogenesis when it is less deleterious.
During fetal myogenesis, we show that ROS levels become
abnormally high at the onset of differentiation in the absence of
Pitx2/3, leading to accumulation of DNA lesions marked by(B) GFP-positive cells isolated from conditional mutant Pitx2flox/flox:Pitx3/flox:P
absence (Ctrl) of 0.5 mM4-OHT. After 72 hr of culture, samples were analyzed by q
Gapdh transcripts in mutant/control cells, expressed as a log ratio (n = 3 embryo
(C and D) Mutant Pitx2flox/flox:Pitx3/flox:Pax3GFP/+:R26RCre-ERT2/+ and control Pit
4-OHT intraperitoneal injection of pregnant mothers at E8.5 and used for isolatio
(C) RNA was analyzed by qPCR for antioxidant enzyme transcripts relative to Gap
embryos; mean ± SD, *p < 0.05).
(D) GFP-positive cells isolated from Pitx2flox/flox:Pitx3/flox:Pax3GFP/+:R26RCRE-E
(Ctrl) of 0.5 mM 4-OHT and processed for protein extraction. Western blot anal
proteins.
The experiments were performed with three independent cultures, and a represe
(E) Antioxidant total capacity was measured (n = 3 embryos; mean ± SD, *p < 0.
(F) ChIP analysis for the presence of Pitx2/3 on Nrf1 regulatory sequences (black)
isolated from the trunk and limbs of wild-type embryos at E13.5. The location o
binding, is indicated for the Nrf1 gene on the right.
(G) Activation of theNrf1 promoter by Pitx2 and Pitx3. 293 cells were transfected w
wt-luc). Dose response is shown for cotransfection of increasing amounts of Pit
activation (n = 3 independent experiments, each performed in duplicate, mean ±
(H) ChIP analysis for the presence of Pitx2/3 and Nrf1 onMt1, Aldh1a1, SOD1, an
trunk and limbs of wild-type embryos at E13.5. The y axis shows the average perce
gene (black) or negative control regions (gray) located close to each gene. Results
on three independent chromatin preparations, *p < 0.05.
(I) Scheme for proposed targets of Pitx2/3 and Nrf1.
DevegH2AX foci in Myogenin-positive cells. DNA lesions due to
oxidation are processed by the base excision repair pathway
(Narciso et al., 2007). In myogenic cells, this pathway is activated
in proliferating cells before differentiation and involves cell cycle
arrest coupled with a transient block of transcription of muscle-
specific genes referred to a differentiation checkpoint (Puri et al.,
2002). Such a mechanism, which would permit genome repair
before the differentiation program begins, is no longer present
in differentiating cells (Narciso et al., 2007). We provide evidence
that myogenic cells at the onset of differentiation, which cannot
activate the base excision repair pathway, rely upon apoptosis
as a cellular response to oxidative DNA damage.
In conclusion, the myogenic system clearly illustrates the
importance of regulating the redox state at the onset of cell
differentiation. During fetal myogenesis, Pitx2/3 control this
redox state through the regulation of Nrf1 and of antioxidant
pathways. Their absence results in a major upregulation of
ROS levels which reach a pathological threshold with conse-
quent death of differentiating cells. The Pitx2/3 transcription fac-
tors are thus key regulators of the intracellular redox state during
development.
EXPERIMENTAL PROCEDURES
Animal Handling and Genotyping
Pitx2-floxed (Pitx2flox/+) mice were generously provided by S. Camper and
P. Gage. Pitx3-floxed(neo) (Pitx3flox) and Pitx3 null (Pitx3) alleles have been
already described elsewhere (L’Honore´ et al., 2007). The Pitx3flox allele with
neo is a hypomorph, expressed as 50% of the wild-type allele. As Pitx2/flox:
Pitx3/flox mice are barely viable and fertile, we used Pitx2flox/flox:Pitx3/flox
mice. Pax3Cre/+,HSA-Cre, andMSD-cremice were generously given by J. Ep-
stein (Engleka et al., 2005), J. Melki (Miniou et al., 1999), and A. Gossler (Beck-
ers et al., 2000), respectively. R26RmTomato-STOP-mGFP/+, R26RCRE-ERT2/+, and
R26Rflox-lacZ/+ reporter mice were obtained from the Jackson Laboratories.
Genotyping was carried out by PCR using DNA isolated from the amniotic
membrane of embryos or from adult tail sections. All animal procedures
were approved and conducted in accordance with the Institut Pasteur animal
ethics committee, following the regulations of the Ministry of Agriculture and
the European Community guidelines.ax3GFP/+:R26RCre-ERT2/+ embryos were cultured in the presence (4-OHT) or
PCR for transcripts of antioxidant transcription factors and enzymes relative to
s; mean ± SD, *p < 0.05).
x2flox/+:Pitx3/+:Pax3GFP/+:R26RCre-ERT2/+ embryos at E13.5 were obtained by
n by flow cytometry of the Pax3GFP-Low population.
dh transcripts in control/mutant (Ctrl/Mut) cells, expressed as a log ratio (n = 2
RT2/+ embryos were cultured for 72 hr in the presence (+4-OHT) or absence
ysis indicated the level of Pitx2, Pitx3, Nrf1, SOD1, Mt1, Gsta1, and Aldh1a1
ntative experiment is shown.
05).
and negative control regions (gray), as indicated, was performed on chromatin
f PitxREs, histone marks for active chromatin and RNA polymerase II (Pol II)
ith a luciferase reporter construct containing Nrf1 regulatory sequences (Nrf1-
x2 and Pitx3 expression plasmids. Mutations of both PitxRE prevented trans-
SD, *p < 0.05).
d Gsta1 regulatory sequences was carried out on chromatin prepared from the
ntage of immunoprecipitation compared to input for regulatory regions of each
presented are the average ± SD of three different ChIP experiments performed




Figure 6. Pitx2/3 Mutant Cells Are Characterized by Impaired Mitochondrial Function at the Onset of Differentiation
(A–C) GFP-positive cells from Pax3GFP/+ embryos at E13.5 were separated by flow cytometry and cultured. (A) Cells were transfected 24 hr after plating with
siRNA directed against SOD1, Gst1a, and Mt1 transcripts or with siControl. As a positive control, GFP-positive cells from inducible mutant Pitx2flox/flox:
Pitx3/flox:Pax3GFP/+:R26RCRE-ERT2/+ embryos at E13.5 were separated by flow cytometry and cultured in the presence of 4-OHT without any transfection. After
96 hr of culture, cells were (B) processed for quantification of ROS content with Cell Rox, expressed as absolute units (A.U.), or (C) analyzed by immunocyto-
chemistry using the TUNEL reaction. TUNEL-positive cells were counted and quantified as the percentage of total cells (n = 3 independent transfections, each
performed in duplicate; mean ± SD, *p < 0.05).
(D and E) Mutant Pitx2flox/flox:Pitx3/flox:Pax3GFP/+:R26RCRE-ERT2/+ and control Pitx2flox/+:Pitx3/+:Pax3GFP/+:R26RCRE-ERT2/+ embryos at E13.5 were obtained by
4-OHT intraperitoneal injection of pregnant mothers at E8.5 and used for isolation by flow cytometry of the Pax3GFP-Low population.
(D) RNA was analyzed by qPCR for transcripts of Tfam and respiratory chain components relative to Gapdh transcripts in mutant (mut) /control (ctrl) cells, ex-
pressed as a log ratio (n = 2 embryos; mean ± SD, *p < 0.05).
(E) Pax3GFP-Low cells were used after purification for quantification of the NAD+/NADH ratio (n = 2 embryos; mean ± SD, *p < 0.05).
(F and G) GFP-positive cells isolated from conditional mutant Pitx2flox/flox:Pitx3/flox:Pax3GFP/+:R26RCRE-ERT2/+ embryos were cultured in the presence (4-OHT) or
absence (Ctrl) of 0.5 mM 4-OHT. After 72 hr of culture, samples were processed for (F) quantification of ATP content and (G) mitochondrial ROS levels expressed
as absolute units (A.U.) (n = 3 embryos for each gene; mean ± SD, *p < 0.05).
(H–J) GFP-positive cells isolated from conditional mutant Pitx2flox/flox:Pitx3/flox:Pax3GFP/+:R26RCRE-ERT2/+ embryos were cultured in the presence of 0.5 mM
4-OHT. After 24 hr of culture, cells were transfected with siRNA directed against Tfam transcripts or siControl. Cells were processed for immunohistochemistry
using (I) Myogenin antibodies or (J) TUNEL staining at 96 hr. (I) Results were quantified by counting positive and negative nuclei. Data represent the mean number
of nuclei counted in more than 10 areas per plate for cultures from three independent transfections. (J) TUNEL-positive cells were counted and quantified as the
percentage of total cells (n = 3 embryos; mean ± SD, *p < 0.05).
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Mouse embryos were collected after natural overnight mating. Noon
of the day on which a vaginal plug was detected was considered
as E0.5, and embryos were staged by counting the number of
somites. Whole-mount in situ hybridization was performed as previ-
ously described (L’honore´ et al., 2010), using digoxigenin-labeled ribop-
robes for Myogenin. Whole-mount X-Gal and whole-mount antibody
staining were performed as described elsewhere (Coulon et al., 2007;
Gre´goire and Kmita, 2008) with modifications (see Supplemental
Information).402 Developmental Cell 29, 392–405, May 27, 2014 ª2014 Elsevier InImmunohistochemistry, Immunofluorescence, and Western Blot
Western blot, immunohistochemistry, and immunofluorescence were carried
out as described elsewhere (L’Honore´ et al., 2007; Relaix et al., 2006). Anti-
bodies and kits used for TUNEL assay and EdU staining are detailed in the
Supplemental Information. GFP and Tomato detection and pictures were
obtained using an Apotome.
Primary Cell Purification and Culture
E13.5 embryos were dissected to obtain trunk and limbs. Care was taken to
eliminate internal organs and the neural tube. Embryo tail fragments werec.
Figure 7. Rescue of the Differentiation
Defect of Pitx2/3 Mutant Cells by Nrf1
Expression
(A–C) GFP-positive cells from inducible mutant
Pitx2flox/flox:Pitx3/flox:Pax3GFP/+:R26RCRE-ERT2/+
embryos at E13.5 were separated by flow cy-
tometry and cultured in the presence (4-OHT) or
absence (Ctrl) of 0.5 mM 4-OHT. Fourteen hours
after plating, cells were infected with lentiviral
particles expressing the red fluorescent protein
(RFP) reporter gene alone or Nrf1 with the reporter
RFP (RFP-Nrf1).
(A) After 120 hr of culture, control and mutant cells
were stained with DAPI and analyzed by immu-
nocytochemistry using RFP (red) and Troponin T
(green) antibodies.
(B) RFP- and Troponin T-double-positive cells
were counted and quantified as a percentage of
total RFP-positive cells (n = 5 embryos; mean ±
SD, *p < 0.05).
(C) After 72 hr of culture, cells transduced by RFP
or RFP-Nrf1 were incubated with Cell Rox, tryp-
sinized, and analyzed by flow cytometry to mea-
sure fluorescence intensity. (n = 3 embryos for
each gene; mean ± SD, *p < 0.05).
(D and E) In (D), a model of Pitx2/3 gene function
during fetal myogenesis is shown: Pitx2/3 genes
prevent excessive oxidative stress during differ-
entiation through the regulation of Nrf1 and genes
for antioxidant enzymes. (E) In their absence,
differentiating cells accumulate excessive ROS
levels due to low expression of antioxidant en-
zymes and defective mitochondrial respiration,
leading to DNA damage and apoptosis. MyHC,
myosin heavy chain; TnT, troponin; Mt, mito-
chondria.
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described elsewhere (Montarras et al., 2005; Relaix et al., 2006) with modifi-
cations (see Supplemental Information). 4-OHT was prepared and used as
described elsewhere (Lepper et al., 2009) with modifications (see Supple-
mental Information). NAC (Sigma) was diluted at 0.5 M in H2O before each
experiment and used for cell seeding at 5 mM in growth medium or added
to cell culture at 10 mM 3 hr before Cell Rox analysis. Resveratrol (Enzo
Life Sciences) was diluted at 0.05 M in EtOH before each experiment and
added to cell culture at 25 mM. Trolox (Abcam) was stored as a 1 mM
solution at 20C in DMSO and added at 10 mM to cell cultures. BSO
(Enzo Life Sciences) was diluted at 5 mM in H2O before each experiment
and added to cell cultures at 10 mM.
RNA Extraction and Quantitative Real-Time PCR Analysis
Cells were collected after flow cytometry in RLT buffer (QIAGEN) for RNA
extraction or plated on gelatin-coated dishes in growth medium supple-
mented, or not supplemented, with 4-OHT and/or NAC before RNA extraction.
Total RNA was extracted and purified after DNase treatment (Promega) using
the RNAeasy Micro kit (QIAGEN) and was reverse-transcribed into cDNA,
based on instructions provided by the Transcriptor cDNA synthesis kit
(Roche). Quantitative real-time PCR was performed on a StepOnePlus PCR
machine (Applied Biosystems) using the FastStart Universal SYBR Green
Master (Roche).
Metabolic Analysis
ROS quantification was performed by microscopy or flow cytometry using the
Cell ROX and theMitoSOX probes (Invitrogen). The following kits were used for
metabolic analysis according to manufacturer’s instructions: TAC kit (Abcam),DeveGSH colorimetric detection kit, and NAD+/NADH detection and ATP quantifi-
cation kits (BioVision). For details about these methodologies, see Supple-
mental Information.
ChIP
ChIP was performed as described elsewhere (Coulon et al., 2007; Navarro
et al., 2010) with modifications (see Supplemental Information).
Lentiviral Production, Cell Infection, siRNA Transfection, and
Transactivation Assays
Lentiviral vectors CMV-NRF1-RFP-2A and RFP-2Awere purchased from abm.
siRNA were purchased from Origene (Tfam) and Santa Cruz Biotechnology
(Mt1, Gsta1, SOD1). Tfam and Aldh1a1 promoter mutants were generated
using a commercial kit (Stratagene) according to the manufacturer’s instruc-
tions and transfected into 293 cells. Details about these methodologies can
be found in the Supplemental Information.
Statistical Analysis
All experiments were carried out on a minimum of three embryos. All data are
presented as mean and SD. The Student’s t test was applied. A p value < 0.05
was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.devcel.2014.04.006.lopmental Cell 29, 392–405, May 27, 2014 ª2014 Elsevier Inc. 403
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